120 related articles for article (PubMed ID: 38178637)
1. Identifying missed opportunities for hepatitis C virus antenatal testing and diagnosis in England.
Hibbert M; Simmons R; Sabin CA; Mandal S; Desai M
J Viral Hepat; 2024 Mar; 31(3):131-136. PubMed ID: 38178637
[TBL] [Abstract][Full Text] [Related]
2. Anti-Hepatitis C (HCV) test positivity and new HCV diagnoses among women tested in antenatal services in England between 2015-2019.
Hibbert M; Simmons R; Mandal S; Sabin CA; Desai M
Midwifery; 2023 Dec; 127():103863. PubMed ID: 37931465
[TBL] [Abstract][Full Text] [Related]
3. Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi-ethnic population: Universal screening is more comprehensive.
Carey I; Christiana M; Marie-Ange M; Teresa B; Maria GV; Dusheiko G; Agarwal K
J Viral Hepat; 2022 Dec; 29(12):1079-1088. PubMed ID: 36138559
[TBL] [Abstract][Full Text] [Related]
4. Understanding current antenatal Hepatitis C testing and care in maternity services in England.
Vusirikala A; Threadgold G; Roche R; Hibbert M; Simmons R; Webb S; Gillyon-Powell M; Desai M; Mandal S
J Perinat Med; 2024 Jun; 52(5):515-519. PubMed ID: 38640060
[TBL] [Abstract][Full Text] [Related]
5. A rapid review of antenatal hepatitis C virus testing in the United Kingdom.
Hibbert MP; Simmons R; Mandal S; Sabin CA; Desai M
BMC Pregnancy Childbirth; 2023 Nov; 23(1):823. PubMed ID: 38017404
[TBL] [Abstract][Full Text] [Related]
6. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.
Ward C; Tudor-Williams G; Cotzias T; Hargreaves S; Regan L; Foster GR
Gut; 2000 Aug; 47(2):277-80. PubMed ID: 10896922
[TBL] [Abstract][Full Text] [Related]
8. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
9. Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England.
Hibbert M; Simmons R; Harris H; Desai M; Sabin CA; Mandal S
J Viral Hepat; 2023 Aug; 30(8):646-655. PubMed ID: 36929670
[TBL] [Abstract][Full Text] [Related]
10. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
11. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
[TBL] [Abstract][Full Text] [Related]
12. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
14. Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?
Orkin C; Jeffery-Smith A; Foster GR; Tong CY
BMJ Open; 2016 May; 6(5):e010661. PubMed ID: 27231001
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.
Enkelmann J; Gassowski M; Nielsen S; Wenz B; Roß S; Marcus U; Bremer V; Zimmermann R;
Harm Reduct J; 2020 Jan; 17(1):7. PubMed ID: 31924208
[TBL] [Abstract][Full Text] [Related]
16. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
18. Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study.
Ireland G; Simmons R; Hickman M; Eastwood B; Ramsay M; Mandal S
Int J Drug Policy; 2019 Oct; 72():55-60. PubMed ID: 31257040
[TBL] [Abstract][Full Text] [Related]
19. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
20. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
